Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats
about
Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin TreatmentContributions of academic laboratories to the discovery and development of chemical biology toolsCannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases.The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioidsAcute resistance exercise induces antinociception by activation of the endocannabinoid system in ratsCB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands.Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity.Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawalMechanisms involved in extraterritorial facial pain following cervical spinal nerve injury in rats.NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain?CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor painPromising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionIn vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probeAttenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in ratsActivation of cannabinoid receptor 2 inhibits experimental cystitisBilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain modelThe monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation.Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling.Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal modelCurrent and emerging "at-site" pain medications: a reviewIs there any clinically relevant cannabinoid-induced analgesia?Endocannabinoid system and pain: an introduction.Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.Comparative antinociceptive effect of arachidonylcyclopropylamide, a cannabinoid 1 receptor agonist & lignocaine, a local anaesthetic agent, following direct intrawound administration in rats.Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.Nociceptor plasticity: A closer look.Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats.Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain.Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain.Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms.
P2860
Q27324350-B55B6A89-082A-4BEA-B72E-3B02A1D72CE2Q28389188-BE9221FE-1010-4FBA-9313-DE1A23A31D0CQ34023238-E17D59D6-74A7-4B78-9290-B012184321E0Q34059667-C36D9AC9-DB1E-4E49-A0ED-682A74239355Q34071059-DD969321-FC4C-410F-9BFF-ED7500FE7D08Q34186015-59409F2D-644F-463B-A949-A328039E5AB9Q34233536-50E47E67-0803-4505-84E7-640FD5BEC55AQ34241636-D73B5035-3B9D-43EB-BA3D-78000809038FQ34376548-1BC3F19A-4E7A-478A-888E-90983C981B66Q34403197-6FF3D182-5225-48A1-A730-EADBABB24CD2Q34623682-93DACAC8-F625-4A4C-A62F-79A500380643Q34739707-CDB103B8-5FF8-4CA6-A9A5-9F31B6A02670Q35030056-B0326FE1-C13D-4CD0-A680-73DC34FF221DQ35162945-3226FB32-000D-4525-B088-2AC5019CFEADQ35499568-40ED91CD-B4D6-4524-95CB-1C9EA321D4A0Q35656587-1F6ECDD4-82D3-44FE-8557-5885C1965973Q35689152-B3202F83-0F0D-41A9-B8EC-BA7EC541604FQ35745959-ECBBD84F-6B6A-4DC9-945C-376A6DF98E3BQ36176531-10EBDB21-D3DA-47CF-925F-F1310D697526Q36626501-BE7EA785-A2B6-4E42-B106-36EF98BC59E1Q36838206-BCC570B9-7B35-495F-8E91-1A2CE6DB8E6DQ36999759-1344EF2B-B22F-42C1-8A49-A04EE1D9CB71Q37030457-A4796258-08DD-46EE-9F04-DB6210C931E0Q37676906-9D18204E-3040-411A-A7CA-C82CA3AA1A4CQ37686101-7B94D868-DCAB-4903-8A02-4FABEC7A7F73Q37716463-44AB9DC0-00A9-4CED-8188-A6495A45A516Q37937444-277A1BB4-975C-46B1-BE23-7DF1BE07BB6EQ38003023-FFC6B68C-AACE-4628-9166-05B598793271Q38154691-A2FF5343-276E-4C34-BB7C-6C0E14EFAAE2Q38166997-5D970C9F-CACE-4818-AA4D-AC69D0C09CDCQ38600704-45F2FFEE-F6FE-4B63-B5DD-F29C60909614Q39157616-F39763DC-204B-4D73-A68B-DD785D60781AQ39248070-7639EC44-4A78-459E-A9BA-67556AE688F1Q39274311-6C3C38E1-87BB-45BD-8055-2F94AF6858D1Q39295296-A40CE97A-0564-4694-B0EE-56C4EFA51664Q39360618-49F459D0-72B8-4D5B-8DEE-7684FD6AD16DQ39467487-AE897005-4E06-4D31-8DED-0FC9B11B8AD0Q41665044-07426EB4-ABDC-489A-9372-A6CD29747282Q41863571-677B45FD-3133-41D7-A53E-D6B86A1714C2Q42062642-4FF7443A-820D-4731-B835-C7595065CAEE
P2860
Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Central and peripheral sites o ...... europathic pain models in rats
@en
Central and peripheral sites o ...... europathic pain models in rats
@nl
type
label
Central and peripheral sites o ...... europathic pain models in rats
@en
Central and peripheral sites o ...... europathic pain models in rats
@nl
prefLabel
Central and peripheral sites o ...... europathic pain models in rats
@en
Central and peripheral sites o ...... europathic pain models in rats
@nl
P2093
P2860
P921
P1476
Central and peripheral sites o ...... europathic pain models in rats
@en
P2093
Anita K Salyers
Betty B Yao
Bradley A Hooker
CenChen Zhan
Chang Z Zhu
Erica J Wensink
Gin C Hsieh
Madhavi Pai
Michael D Meyer
Michael J Dart
P2860
P304
P356
10.1111/J.1476-5381.2010.01046.X
P407
P577
2011-01-01T00:00:00Z